Mississauga, ON -- (SBWIRE) -- 08/06/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "RegeneRx Provides Update on Clinical Trials."
Companies mentioned in this article include RegeneRx Biopharmaceuticals Inc. (OTCQB:RGRX).
Article Excerpt:
According to the Mayo Clinic's Center for Regenerative Medicine, current evidence-based and palliative treatments are increasingly unable to keep pace with patients' needs, especially given the aging population.
The Center notes that right now there are few effective ways to treat the root causes of many diseases. This is where regenerative medicine comes in. The Mayo Clinic describes regenerative medicine as a game-changing area of medicine with the potential to fully heal damaged tissues and organs. Not surprisingly, the patient and the investor communities are excited about regenerative medicine.
Of course, the concept of regenerative medicine isn't new. According to the Center for Regenerative Medicine, the first bone marrow and solid-organ transplants were performed decades ago. However, with the advances made in the areas of developmental and cell biology, immunology, and other fields, have unlocked new opportunities to refine existing therapies, the center notes.
There are several U.S.-based biotechs currently focusing on the regenerative medicine field. One such company is Rockville, Maryland-based RegeneRx Biopharmaceuticals Inc. (OTCQB:RGRX). The company is currently in clinical-stage and focuses on tissue protection, repair and regeneration.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/560/regenerx-provides-update-on-clinical-trials.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.